Page last updated: 2024-11-02

pentamidine and Eosinophilia, Pulmonary

pentamidine has been researched along with Eosinophilia, Pulmonary in 2 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dupon, M1
Malou, M1
Rogues, AM1
Lacut, JY1
Lawrence, TE1
Millecchia, LL1
Fedan, JS1

Other Studies

2 other studies available for pentamidine and Eosinophilia, Pulmonary

ArticleYear
Acute eosinophilic pneumonia induced by inhaled pentamidine isethionate.
    BMJ (Clinical research ed.), 1993, Jan-09, Volume: 306, Issue:6870

    Topics: Acute Disease; Administration, Inhalation; Adult; Female; HIV Infections; Humans; Pentamidine; Pulmo

1993
Fluticasone propionate and pentamidine isethionate reduce airway hyperreactivity, pulmonary eosinophilia and pulmonary dendritic cell response in a guinea pig model of asthma.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 284, Issue:1

    Topics: Androstadienes; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Dendritic Cells;

1998